Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8461328 Tricyclic heterocyclic compounds, compositions and methods of use thereof

Patent 8461328 was granted and assigned to Genentech on June, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

84613280

Patent Inventor Names

Bohdan Waszkowycz0

Emily Hanan0

Hazel Joan Dyke0

Janusz Kulagowski0

Joseph Lyssikatos0

Mark Zak0

Michael Koehler0

Paul Gibbons0

...

Date of Patent

June 11, 2013

Patent Application Number

130048080

Date Filed

January 11, 2011

Patent Citations Received

‌

US Patent 12024517 Salts of an FGFR inhibitor

‌

US Patent 11713322 Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

‌

US Patent 11787807 Small molecule inhibitors of the JAK family of kinases

‌

US Patent 11787788 Benzimidazole derivatives, and pharmaceutical compositions and methods of use thereof

‌

US Patent 11827638 Imidazopyrrolopyridine as inhibitors of the JAK family of kinases

Patent Primary Examiner

‌

Janet Andres

Patent abstract

The invention provides novel compounds of formula I having the general formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8461328 Tricyclic heterocyclic compounds, compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API